MeaTech 3D Ltd. (Nasdaq: MITC) announced key leadership changes as part of its strategy to advance business objectives. CEO Sharon Fima plans to step down, transitioning to a role on the scientific advisory board. Arik Kaufman will take over as CEO, bringing extensive experience in food-tech. The board also saw changes with Steven H. Lavin and Danny Ayalon stepping down, while Yaron Kaiser was appointed as Chairperson. The company focuses on cultured meat technologies, aiming for sustainable production alternatives.
MeaTech 3D Ltd. (Nasdaq: MITC) announced a milestone achievement in cultivated meat by bioprinting a 3.67 oz (104-gram) steak, the largest of its kind produced to date. Utilizing proprietary technology, the steak is made from real muscle and fat cells, free from soy or pea protein. The company aims to scale production and further enhance its bioprinting processes. According to CEO Sharon Fima, this breakthrough validates their technologies and positions them as leaders in the cultured meat market, emphasizing sustainability and high-quality meat alternatives.
MeaTech 3D Ltd (MITC) announced its hybrid meat products will be showcased at multiple European tasting events in October 2021, including the Anuga Global Trade Fair and the New Food Conference. The company believes that hybrid products, which combine cultured animal fats with plant-based ingredients, can enhance the consumer experience compared to fully plant-based alternatives. This strategy is aimed at generating initial revenue while developing pure cultivated meat products. The tasting events are exclusive to in-person attendees, indicating a focused approach to market introduction.
A collective led by Ashton Kutcher and Guy Oseary has partnered with MeaTech 3D Ltd. (Nasdaq: MITC) to accelerate the company's growth in cultured meat production. MeaTech aims to revolutionize sustainable meat alternatives using advanced 3D bioprinting and tissue engineering technologies. Kutcher expressed confidence in MeaTech's potential to lead the market, while CEO Sharon Fima emphasized the strategic collaboration's importance for achieving their goals. MeaTech is focused on developing premium meat products and has a track record since 2019.
MeaTech 3D Ltd. (Nasdaq: MITC) announced a breakthrough in cultivated meat production, successfully cultivating over 700 grams of pure chicken fat biomass in a single run. This marks a significant advancement as it is believed to be the first public demonstration of this quantity of cultivated cell biomass grown entirely outside of an animal. The company aims to leverage this achievement towards the commercialization of hybrid meat products, combining cultured animal fats with plant-based ingredients to enhance consumer experiences.
MeaTech 3D Ltd. (Nasdaq: MITC) announced the filing of a provisional patent application for a novel method to produce cultured fat using 100% plant-sourced inputs. This technology aims to differentiate embryonic mesenchymal stem cells into adipocytes, replicating the intramuscular fat found in marbled meats like Wagyu beef. The initiative seeks to simplify cultured meat production, reducing costs and reinforcing the company's commitment to animal input-free processes. MeaTech holds seven patent applications with a focus on sustainable and advanced meat production technologies.
MeaTech 3D Ltd. (Nasdaq: MITC) reported strong progress in H1 2021, driven by the acquisition of Peace of Meat and the establishment of MeaTech Europe. The company achieved a cash position of $30.6 million, driven by its $28 million Nasdaq IPO. R&D expenses rose to $2.1 million, contributing to an operating loss of $6.7 million. Total comprehensive loss was $7.7 million, or $0.06 per share. Recent initiatives include developing cultured pork, a pilot plant for chicken fat in Belgium, and signing a letter of intent with Tiv Ta'am to collaborate on cultured meat distribution.
MeaTech 3D Ltd. (Nasdaq: MITC) is set to announce its financial results for the first half of 2021 on August 16, 2021. A conference call will follow at 9:00 am ET, hosted by management to discuss the results and a business update. Interested participants can join via specific phone lines or through a live webcast available on the company’s website. MeaTech, headquartered in Israel, is at the forefront of the cultivated meat sector, focusing on innovative manufacturing technologies for cell-based proteins.
MeaTech 3D Ltd. (Nasdaq: MITC) announced on July 6, 2021, the initiation of cultivated pork research and development. This expansion aims to develop stable porcine cell lines for future mass production of cultivated pork, complementing existing beef and chicken offerings. The company believes this move will enhance its market potential, as pork is the most consumed meat globally. CEO Sharon Fima emphasized that the goal is to create sustainable and slaughter-free meat alternatives.
MeaTech 3D Ltd. (Nasdaq: MITC) announces its virtual presentation at the LD Micro Invitational XI on June 10, 2021, at 11:00am EDT. Head of Business Development, Simon Fried, expressed excitement for engaging with investors, marking the company's first significant presentation since its IPO in March. The event highlights MeaTech's focus on cultured meat technologies and its international business strategy. The LD Micro Invitational runs from June 8 to June 10, featuring around 180 companies. To attend, investors can register at LD Micro.